[Cognitive-behavioral therapy in panic disorder].

about

Anxiety, panic disorder and coronary artery disease: issues concerning physical exercise and cognitive behavioral therapy.Intolerance of uncertainty as a contributor to fear and avoidance symptoms of panic attacks.

P2860

Q37859781-C89E630A-887C-49CC-A839-9FD3DBAF0EB1 Q39403824-220609C1-D3DD-4B48-A1FE-5D55CE2540D6

P2860

[Cognitive-behavioral therapy in panic disorder].

Item

http://www.wikidata.org/entity/Q46224807

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

[Cognitive-behavioral therapy in panic disorder].

@en

[Cognitive-behavioral therapy in panic disorder].

@nl

type

Item

label

[Cognitive-behavioral therapy in panic disorder].

@en

[Cognitive-behavioral therapy in panic disorder].

@nl

prefLabel

[Cognitive-behavioral therapy in panic disorder].

@en

[Cognitive-behavioral therapy in panic disorder].

@nl

P1476

[Cognitive-behavioral therapy in panic disorder].

@en

P2093

Aristides Volpato Cordioli

http://www.w3.org/2001/XMLSchema#string

Elizeth Heldt

http://www.w3.org/2001/XMLSchema#string

Gisele Gus Manfro

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder

Quality of life in individuals with anxiety disorders.

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Panic: course, complications and treatment of panic disorder.

Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.

Benzodiazepine discontinuation difficulties in panic disorder: conceptual model and outcome for cognitive-behavior therapy.

The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy.

Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.

Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.

P304

s81-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1590/S1516-44462008000600005

http://www.w3.org/2001/XMLSchema#string

P407

non-English

P478

30 Suppl 2

http://www.w3.org/2001/XMLSchema#string

P50

Michael W. Otto

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240299241

http://www.w3.org/2001/XMLSchema#string

P698

19039448

http://www.w3.org/2001/XMLSchema#string

[Cognitive-behavioral therapy in panic disorder].

about

P2860

P2860

[Cognitive-behavioral therapy in panic disorder].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698